Viruses Genetically Engineered to Kill Bacteria Rescue Girl with Antibiotic-Resistant Infection

Seventeen-year-old Isabelle Carnell has battled a drug-resistant infection of Mycobacterium abscessus for half her life. In 2017, a week after a double lung transplant, the incision wound turned bright red and was rapidly spreading, erupting in weeping sores and swollen nodules across her frail body.

Helen Spencer, Carnell's physician decided to take a gamble on what seemed like a far-fetched idea: phages, viruses that can destroy bacteria and have a long—if checkered—history as medical treatments. Spencer collaborated with leading phage researchers, who concocted a cocktail of the first genetically engineered (GE) phages ever used as a treatment—and the first directed at a Mycobacterium, a genus that includes tuberculosis (TB). Six months after the tailor-made phage infusions, Isabelle's wounds healed and her condition improved with no serious side effects.

Spencer's team worked with phage researcher Graham Hatfull of the University of Pittsburgh in Pennsylvania. Hatfull and his team curate a collection of more than 15,000 phages, one of the world's largest. The team spent three months searching for phages that could kill M. abscessus isolated from Isabelle's wounds and sputum and found three.

For more details, read the news article in Science.


 

This article is part of the Crop Biotech Update, a weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Aquisition of Agri-Biotech Applications SEAsiaCenter (ISAAA)

Subscribe to Crop Biotech Update Newsletter
Crop Biotech Update Archive
Crop Biotech Update RSS
Biofuels Supplement RSS

Article Search: